EUS-guided fine-needle core liver biopsy with a modified one-pass, one-actuation wet suction technique comparing two types of EUS core needles

Abstract

Background and study aims We compared the diagnostic yield and specimen adequacy in EUS-guided parenchymal biopsies between two types of EUS 19 G core needles.

Patients and methods This is a retrospective study of 420 patients at two tertiary medical centers in Florida with unexplained abnormal liver associated tests were referred for EUS evaluation of biliary obstruction and pancreatic pathology. EUS-guided liver biopsy (EUS-LB) was performed at the same session after biliary obstruction was excluded. We compared intact specimen length (ISL), total specimen length (TSL), complete portal triads (CPT) and adverse events (AE). Welch’s T and Tukey tests were used for ISL, TSL and CPT.

Results A total of 210 patients underwent EUS-LB using a Franseen needle, 210 patients using a fork-tip needle. Median patient age was 52 years (15.63) and 238 (56.7 %) were female. The fork-tip needle had a mean ISL of 2.7 (1.1 SD) cm, TSL of 6 cm (2.1 SD), and mean 19.5 CPT (8.5 SD) Abdominal pain occurred in 35 patients (17 %) post-procedure and was managed with supportive care. Two patients required intravenous (IV) narcotic administration. Subcapsular hematomas occurred in 1 (0.5 %) patients. The Franseen needle had a mean ISL of 3.1 cm (1.3 SD), TSL of 6.5 cm (2.6 SD), and mean of 24 CPT (8.8 SD). Abdominal pain occurred in four patients (2 %) post-procedure, which resolved in all patients after IV narcotic administration. Subcapsular hematomas occurred in 1 (0.5 %) and bile leak in 1(0.4 %) patients.

Conclusions Use of the Franseen needle resulted in better liver core samples than that obtained with a fork-tip needle.

Publication History

Received: 17 November 2019

Accepted: 09 April 2020

Article published online:
16 June 2020

• References

• 1 Sheen V, Nguyen H, Jimenez M. et al. Routine laboratory blood tests may diagnose significant fibrosis in liver transplant recipients with chronic hepatitis C: a 10 year experience. J Clin Transl Hepatol 2016; 4: 20-25
• 2 Rockey DC, Caldwell SH, Goodman ZD. et al. American Association for the Study of Liver Diseases. Liver biopsy. Hepatology 2009; 49: 1017-1044
• 3 Cross TJ, Calvaruso V, Maimone S. et al. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection. J Viral Hepat 2010; 17: 546-554
• 4 Mohan BP, Shakhatreh M, Garg R. et al. Efficacy and safety of EUS-guided liver biopsy: a systematic review and meta-analysis. Gastrointest Endosc 2019; 89: 238-246.e3
• 5 Shiha G, Ibrahim A, Helmy A. et al. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int 2017; 11: 1-30
• 6 Saab S, Phan J, Jimenez MA. et al. endoscopic ultrasound liver biopsies accurately predict the presence of fibrosis in patients with fatty liver. Clin Gastroenterol Hepatol 2017; 15: 1477-1478
• 7 Nieto J, Khaleel H, Challita Y. et al. EUS-guided fine-needle core liver biopsy sampling using a novel 19-gauge needle with modified 1-pass, 1 actuation wet suction technique. Gastrointest Endosc 2018; 87: 469-475
• 8 Diehl DL, Johal AS, Khara HS. et al. Endoscopic ultrasound-guided liver biopsy: a multicenter experience. Endosc Int Open 2015; 3: E210-E215
• 9 Oh D, Seo DW, Hong SM. et al. Endoscopic ultrasound-guided fine-needle aspiration can target right liver mass. Endosc Ultrasound 2017; 6: 109-115
• 10 Saraireh HA, Bilal M, Singh S. Role of endoscopic ultrasound in liver disease: Where do we stand in 2017?. World J Hepatol 2017; 29: 1013-1021
• 11 Singh P, Mukhopadhyay P, Bhatt B. et al. Endoscopic ultrasound versus CT scan for detection of the metastases to the liver: results of a prospective comparative study. J Clin Gastroenterol 2009; 43: 367-373
• 12 Parekh PJ, Majithia R, Diehl DL. et al. Endoscopic ultrasound-guided liver biopsy. Endosc Ultrasound 2015; 4: 85-91
• 13 Bravo AA, Sheth SGS. Liver biopsy. N Engl J Med 2001; 344: 495-500
• 14 Magalhães J, Monteiro S, Xavier S. et al. Endoscopic ultrasonography – emerging applications in hepatology. World J Gastrointest Endosc 2017; 9: 378-388
• 15 Gleeson FC, Clayton AC, Zhang L. et al. Adequacy of endoscopic ultrasound core needle biopsy specimen of nonmalignant hepatic parenchymal disease. Clin Gastroenterol Hepatol 2008; 6: 1437-1440
• 16 Schulman AR, Thompson CC, Odze R. et al. Optimizing EUS-guided liver biopsy sampling: comprehensive assessment of needle types and tissue acquisition techniques. Gastrointst Endosc 2017; 85: 419-426
• 17 Mok SRS, Diehl DL. The role of EUS in liver biopsy. Curr Gastroenterol Rep 2019; 21: 6
• 18 Mok SR, Dielh DL, Johal AS. et al. Mo1245 19 versus 22 gauge fine needle biopsy for endoscopic ultrasound guided liver biopsy (EUS-LB): a prospective randomized trial. Gastrointest Endosc 2017; 85: AB473-474
• 19 Ching Companioni RA, Johal AS, Confer B. et al. Mo1349 a prospective randomized trial of 19-gauge (G) aspiration needle versus 19G core biopsy needle for endoscopic ultrasound- guided liver biopsy. Gastrointest Endosc 2018; 87: AB457-AB458
• 20 DeWitt J, Cho CM, Lin J. et al. Comparison of EUS-guided tissue acquisition using two different 19-gauge core biopsy needles: a multicenter, prospective, randomized, and blinded study. Endosc Int Open 2015; 3: E471-E478
• 21 Hasan MK, Kadkhodayan K, Idrisov E. et al. Endoscopic ultrasound-guided liver biopsy using a 22-G fine needle biopsy: a prospective study. Endoscopy 2019; 51: 818-824